HOME
PRESS RELEASES
DOCUMENTATION
Financial Presentations
Financial reports
Universal registration document
Other regulated information
Sustainable Finance
SHAREHOLDERS
Stock exchange
Analyst coverage
Shareholding structure
Shareholder meeting
Dividends
Contacts
Restructuring
FINANCIAL RESTRUCTURING
CAPITAL INCREASES
EN
FR
✕
February 2023
Page d'accueil
2023
February
28 February 2023
Published by
Alexandra Oriano
on
28 February 2023
Categories
2023
Financial Press Releases
The Group
ORPEA publication: ETHICS WITH YOU AND FOR YOU
23 February 2023
Published by
Alexandra Oriano
on
23 February 2023
Categories
2023
Financial Press Releases
The Group
Uncategorized
Extension of the conciliation procedure
14 February 2023
Published by
Jean-François Pillet
on
14 February 2023
Categories
2023
Financial Press Releases
The Group
Uncategorized
Signature of the lock-up agreement relating to the financial restructuring plan
13 February 2023
Published by
admin
on
13 February 2023
Categories
2023
Financial Press Releases
Q4 2022 revenue growth of +8,9%, at €4,681 m
Q4 2022 revenue growth of +8,9%, at €4,681 m
13 February 2023
Published by
Jean-François Pillet
on
13 February 2023
Categories
The Group
Q4 2022 revenue growth of +8,9%, at €4,681 m
9 February 2023
Published by
Alexandra Oriano
on
9 February 2023
Categories
2023
Financial Press Releases
The Group
Downwards thresholds crossing by CPPIB
1 February 2023
Published by
Alexandra Oriano
on
1 February 2023
Categories
Uncategorized
Interview with Emmanuel Hirsch, ORPEA Group’s Director of Medical Ethics, who explains his mission and talks about ethics in our daily actions
You joined ORPEA Group at the start of the year as Director of Medical Ethics; can you give us an initial assessment? Emmanuel Hirsch: As soon
[…]
1 February 2023
Published by
Alexandra Oriano
on
1 February 2023
Categories
2023
Financial Press Releases
The Group
Agreement in principle on the financial restructuring plan with the CDC and a representative group of unsecured financial creditors
